Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Elecsys Troponin T; catalog number 2017644

FDA Recall Z-0870-03 · Posted 2003-05-29

Recall StatusTerminated
Product CodeMMI
Date Initiated2003-04-25
Date Terminated2003-06-19

Reason for Recall

Hemoglobin interference limitation revised downward; hemolyzed samples may result in false negative results.

Firm Action

An Urgent Product Correction letter was mailed to each account, during the week of 4/21/03, advising them not to use hemolyzed specimens with a hemoglobin level equal to, or greater than, 0.1 g/dL.

Root Cause

Other

Distribution Pattern

United States

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑